By Anna Edney - Nov 15, 2012 8:59 AM CT
Hospital pharmacists are backing a call by the Food and Drug Administration for added regulation of compounding companies after a meningitis outbreak, calling it a “gray area” with serious implications.
FDA Commissioner Margaret Hamburg’s request for greater federal power to inspect compounding companies and test their medicines yesterday drew skepticism from House Republicans during a subcommittee hearing yesterday on the outbreak, which has infected 438 people and killed 32. The statement by the hospital pharmacists came in prepared remarks for a probe by the Democratic-controlled U.S. Senate.
Continue reading here
No comments:
Post a Comment